Author Information
Joseph Lee Witztum is a distinguished researcher affiliated with the Department of Medicine at the University of California, San Diego, located in La Jolla, CA. His extensive work focuses on various aspects of cardiovascular health, including lipoproteins, inflammation, and metabolic syndrome. His contributions to the field are widely recognized, making him a prominent figure in medical research.Research Contributions
Joseph Lee Witztum has made significant contributions to the understanding of cardiovascular diseases. His recent work includes research on the effects of Pelacarsen on lipoprotein(a) cholesterol, the generation of cardio-protective antibodies, and the impact of Apolipoprotein C-III reduction on individuals with moderate hypertriglyceridemia and high cardiovascular risk. Additionally, Witztum has explored the role of bioactive lipids in metabolic syndrome, investigated the prevalence and impact of LPA gene variants, and assessed the longitudinal levels of lipoprotein(a) in perinatally HIV-infected children and adolescents. His research also delves into the anti-inflammatory properties of human milk oligosaccharides and the mechanisms of sustained vascular inflammation due to residual inflammatory risk.Aliases
Joseph Lee Witztum has published under several aliases, including Joseph L. Witztum, J. L. Witztum, J. Witztum, Josephl. Witztum, J.l. Witztum, Joseph Witztum, and Joseph L Witztum.Publication and Citation Metrics
| Metric |
Value |
| Total Citations |
63,480 |
| H-index |
131 |
| Total Papers |
532 |
